呼吸道同胞性病毒对喘发展和恶化的影响
Ruixue Ma1, Chenyu Zhang2, Yi Zhang2
1Department of Pediatrics, Xijing Hospital, the Fourth Military Medical University, Xi'an, China.
概括
婴儿期呼吸道同胞性病毒 (RSV) 感染是儿童喘的重要危险因素. 本综述探讨了RSV如何影响免疫系统和呼吸道健康,导致长期呼吸问题和潜在的喘发展.
科学领域:
- 儿童呼吸系统健康问题
- 病毒感染的免疫学
- 喘病因中的环境因素
背景情况:
- 喘是儿童常见的慢性呼吸道炎症疾病,通常由病毒感染引发或恶化.
- 呼吸道同胞性病毒 (RSV) 是婴儿下呼吸道感染的主要原因,与喘发展有关.
- 感染RSV与免疫系统的改变,上皮功能障碍和呼吸道微生物组的变化有关.
研究的目的:
- 审查婴儿RSV感染后的长期呼吸道结果.
- 阐明将RSV与喘发展联系在一起的机制,包括免疫失调和炎症.
- 突出新型预防策略,减少与RSV相关的呼吸道疾病.
主要方法:
- 对婴儿RSV感染和长期呼吸系统健康现有证据的综合文献综述.
- 对将RSV感染与喘联系起来的病理生理机制的分析.
- 评估预防策略的最新进展,包括疫苗和单克隆抗体.
主要成果:
- 早期生活RSV下呼吸道感染是复发性喘息和喘状症状的已知的危险因素.
- RSV感染可能导致免疫失调,慢性呼吸道炎症和改变的基因环境相互作用,导致喘.
- 孕产妇的RSV疫苗和单克隆抗体在减少婴儿严重RSV疾病和随后的喘息方面表现有前途.
结论:
- 婴儿RSV感染是儿童喘发展的关键因素.
- 了解RSV引起的呼吸道炎症的机制是开发有效疗法的关键.
- 新兴的预防策略为缓解RSV感染的长期呼吸系统后果提供了希望.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management
293
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
293
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
205
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
205
Asthma-III: Symptoms and Complications
2.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.4K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K


